<i>In Vitro</i> Activity of Novel Topoisomerase Inhibitors against <i>Francisella tularensis</i> and <i>Burkholderia pseudomallei</i>

Antimicrobial resistance is a global issue, and the investigation of alternative therapies that are not traditional antibiotics are warranted. Novel bacterial type II topoisomerase inhibitors (NBTIs) have recently emerged as a novel class of antibiotics with reduced potential for cross-resistance to...

Full description

Bibliographic Details
Main Authors: Adam O. Whelan, Ian Cooper, Nicola Ooi, David Orr, Kevin Blades, James Kirkham, Amanda Lyons, Kay B. Barnes, Mark I. Richards, Anne-Marie Salisbury, Mark Craighead, Sarah V. Harding
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/6/983